1Kharitonenkov A,Shiyanova TL.FGF-21 as a novel metabolic regulator[J].J Clin Invest,2005;115(6):1627-35.
2Cuevas-Ramos D,Almeda-Valdes P,Aguilar-Salinas CA,et al.The role of fibroblast growth factor 21 (FGF21) on energy balance,glucose and lipid metabolism[J].Curr Diabetes Rev,2009;5(4):216-20.
3Matuszek B,Lenart-Lipińska M,Duma D.Evaluation of concentrations of FGF-21--a new adipocytokine in type 2 diabetes[J].Endokrynol Pol,2010;61(1):50-4.
4Chen WW,Li L,Yang GY,et al.Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus[J].Exp Clin Endocrinol Diabetes,2008;116(1):65-8.
5Zhang X,Yeung DC,Karpisek M,et al.Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans[J].Diabetes,2008;57(5):1246-53.
6Stein S,Stepan H,Kratzsch J,et al.Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia[J].Metabolism,2010;59(1):33-7.
7Berglund ED,Li CY,Bina HA,et al.Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity[J].Endocrinology,2009;150(9):4084-93.
8Chavez AO,Molina-Carrion M,Abdul-Ghani MA,et al.Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance[J].Diabetes Care,2009;32(8):1542-6.
9Hojman P,Pedersen M,Nielsen AR,et al.Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia[J].Diabetes,2009;58(12):2797-801.
10Kharitonenkov A,Shanafelt AB.Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases[J].Biol Drugs,2008;22(1):37-44.
